淨利增速落後營收增速 吉比特(603444.SH)連跌三日股價創4個月新低
格隆匯10月23日丨吉比特(603444.SH)今日繼續下跌,現跌6.69%報474元,最新市值341億元。該股已連續第三日下跌,股價創4個月新低。吉比特昨晚披露三季報,公司2020年前三季度營收20.50億元,同比增31.79%;淨利潤7.95億元,同比增18.62%。其中,第三季度營收6.4億,同比增32.2%;歸母淨利潤2.45億,同比增19.65%。吉比特淨利增速明顯落後營收增速。A股市場遊戲板塊此前已有個股提前出現大跌,市場人士猜測,可能與“買量增長”模式導致成本上升有關。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.